In recent research, @AnaAndersonlab and collaborators identify a major regulator of Th17 cell state, The findings have implications for multiple autoimmune diseases. The work was published in @CellPressNews. Read more: https://t.co/qPezkqw4Rv
Check out our latest online today @ImmunityCP . We show how TCF1 functions to keep Th17 cells in homeostatic state. https://t.co/oJXUEtLVUv Thats right, not just cancer anymore in the Anderson Lab! Congratulations to @Dr_ImmunoMan_D
Happy to announce that I am officially promoted to Full Professor at Harvard Medical School! A very special thank you to my mentor @KuchrooLab and my trainees who trusted me with their careers!
Our work "Pan-cancer mapping of single CD8+ T cells profiles reveals a TCF1:CXCR6 axis regulating CD28 co-stimulation and anti-tumor immunity." is now online @cellrepmed and highlighted here https://t.co/2GjW4xfKtv.
The Society for Immunotherapy of Cancer (SITC) is pleased to offer a free educational program crafted specifically for international audiences, titled “Increasing Access to IO: A Global Webinar Series”. To learn more about the series visit https://t.co/ViJJW2WFcW
Apparently I was beat to the punch! Very proud of @escobar_giulia who spearheaded our understanding of the rules governing reliance on TCF1 for anti-tumor responses upon checkpoint blockade therapy! Many thanks to our collaborator @Luca_Biasco and all lab members who contributed!
Happy to share that our work investigating the reliance on TCF1 in CD8 T cells for response to ICB in different tumor contexts has been published today in @CancerCell
https://t.co/Nc02elxlfn
Amazing way to cap off two days of hard but important work deciding the future directions of cancer immunotherapy with @sitcancer and @SMImmunology @CVanpouilleBox @deborahcollyar and others.
Lots of fun at the end of the @sitcancer Strategic Retreat dinner with incredible scientists, clinicians, and parent advocates! @AnaAndersonlab @CVanpouilleBox @deborahcollyar